Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
or

Predictive Oncology Inc (POAI)

Predictive Oncology Inc (POAI)
0.8931 x 5 0.9100 x 2
Post-market by (Cboe BZX)
0.8923 +0.0247 (+2.85%) 04/22/25 [NASDAQ]
0.8931 x 5 0.9100 x 2
Post-market 0.8932 +0.0009 (+0.10%) 19:51 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.8500
Day High
0.9194
Open 0.8700
Previous Close 0.8676 0.8676
Volume 35,900 35,900
Avg Vol 8,201,136 8,201,136
Stochastic %K 5.34% 5.34%
Weighted Alpha -49.69 -49.69
5-Day Change -0.0677 (-7.05%) -0.0677 (-7.05%)
52-Week Range 0.5500 - 3.0600 0.5500 - 3.0600
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,749
  • Shares Outstanding, K 8,932
  • Annual Sales, $ 1,620 K
  • Annual Income, $ -12,660 K
  • EBIT $ -11 M
  • EBITDA $ -10 M
  • 60-Month Beta 1.11
  • Price/Sales 5.15
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.08
  • Most Recent Earnings $-0.36 on 11/12/24
  • Next Earnings Date 05/13/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Information Systems

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.09
  • Number of Estimates 1
  • High Estimate -0.09
  • Low Estimate -0.09
  • Prior Year -1.04
  • Growth Rate Est. (year over year) +91.35%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8500 +4.98%
on 04/22/25
Period Open: 1.1100
2.6000 -65.68%
on 03/25/25
-0.2177 (-19.61%)
since 03/21/25
3-Month
0.8500 +4.98%
on 04/22/25
Period Open: 1.4800
2.6000 -65.68%
on 03/25/25
-0.5877 (-39.71%)
since 01/22/25
52-Week
0.5500 +62.24%
on 10/15/24
Period Open: 1.1800
3.0600 -70.84%
on 01/06/25
-0.2877 (-24.38%)
since 04/22/24

Most Recent Stories

More News
Predictive Oncology Develops Novel Approach to Identifying Clinically Viable Abandoned Drugs

POAI : 0.8923 (+2.85%)
Renovaro Provides Update to Definitive Agreement with Predictive Oncology

RENB : 0.3482 (-13.32%)
POAI : 0.8923 (+2.85%)
Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update

POAI : 0.8923 (+2.85%)
Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary

POAI : 0.8923 (+2.85%)
Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries

POAI : 0.8923 (+2.85%)
Predictive Oncology Moves to Finalize Definitive Merger Agreement With Renovaro Biosciences

POAI : 0.8923 (+2.85%)
Predictive Oncology Closes Registered Direct Offering

POAI : 0.8923 (+2.85%)
Investors Eye Biotech Sector as Cancer Therapy Market Surges

/CNW/ -- USA News Group News Commentary – Amid the excitement surrounding Project Stargate—the $500 billion investment aimed at revolutionizing AI-driven data...

ONCY : 0.6000 (+4.35%)
RENB : 0.3482 (-13.32%)
POAI : 0.8923 (+2.85%)
DGX : 172.84 (+6.78%)
GRAL : 29.69 (+12.38%)
ONC.TO : 0.84 (+6.33%)
Predictive Oncology Announces Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

POAI : 0.8923 (+2.85%)
Predictive Oncology Reports Positive Results Utilizing Artificial Intelligence for Drug Repurposing

POAI : 0.8923 (+2.85%)

Business Summary

Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS.

See More

Key Turning Points

3rd Resistance Point 0.9939
2nd Resistance Point 0.9566
1st Resistance Point 0.9245
Last Price 0.8923
1st Support Level 0.8551
2nd Support Level 0.8178
3rd Support Level 0.7857

See More

52-Week High 3.0600
Fibonacci 61.8% 2.1012
Fibonacci 50% 1.8050
Fibonacci 38.2% 1.5088
Last Price 0.8923
52-Week Low 0.5500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro